Agent capable of depleting CD8 T cells for the treatment of myocardial infarction or acute myocardial infarction
US10556953B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Oct 11, 2016 |
| Grant date | Feb 11, 2020 |
| Priority date | — |
| Expiry date | Feb 21, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for treating MI or AMI in a subject in need thereof comprising a step of administering to said subject a therapeutically effective amount of an agent capable of depleting CD8 T cells. More particularly, this present invention relates to a method for treating acute myocardial infarction by reducing the size of necrosis and limiting 10 the post ischemic left ventricular remodeling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.